PharmaSource Podcast

• Bold capacity investments lag despite urgent need for decentralised pharma supply chains - Roland Berger

  “What we’re witnessing is a fundamental shift from globalized to decentralized pharma supply chains, yet many companies are hesitant to make the bold capacity investments needed despite recognizing the risks.” – Stephan Fath, Director at Roland BergerStephan Fath is a Director at Roland Berger where he specialises in advising global pharmaceutical, MedTech, and chemical industries. With a dual degree in Business Administration and Chemistry from the University of Dusseldorf, Stephan brings a valuable interdisciplinary perspective to network strategy challenges.In the latest PharmaSource podcast episode, Stephan shares critical insights into how pharmaceutical manufacturing networks are evolving in 2025, highlighting the delicate balance companies must strike between cost efficiency, supply chain resilience, and technological innovation in an increasingly uncertain global landscape.Read the full article

  --------  

  31:12
• CDMO Cultural Alignment: Why the Disney effect is killing partnerships with John Philips

  “Every CDMO is going to give you the Disney effect. I want to see what’s below the street. How is that organisation humming below the surface?” says John Philips, highlighting why superficial evaluations are undermining pharmaceutical outsourcing success.John Philips, President at Innopath Consulting, brings over three decades of experience in CDMO partnerships, including leadership roles at Pii (Pharmaceutics International, Inc.), BioDuro-Sundia, Mikart, and Patheon. His focus on bridging the gap between early-stage development and commercialisation has given him unique insights into what makes CDMO partnerships succeed or fail.In the latest PharmaSource podcast episode, John explains why cultural alignment between sponsors and CDMOs has become increasingly critical as the industry has evolved, yet remains dangerously overlooked in vendor selection processes.Read the full article

  --------  

  30:24
• Recipharm’s CDMO Evolution: Technology Investment Powering Global Growth

  “Every minute, over 1000 patients are using a product manufactured in one of our sites,” reveals Kerstin Vieluf, Head of Sales at Recipharm.Headquartered in Stockholm, Sweden, Recipharm has over 5,900 employees across 17 sites in Europe, US, India, and Israel and serves more than 400 customers globally.In this exclusive interview ahead of CDMO Live, the leadership team outlines how Recipharm is evolving its capabilities, with significant investments in digital prediction tools, expanded development services, and sustainability initiatives. Dr. Vincenza Pironti, (Head of Business Development), Dr. Uwe Hanenberg (Head of Product Development), and Dr. Kerstin Vieluf, (Head of Sales) reveal how technology investment is driving growth.Read the full article

  --------  

  23:53
• Quality Excellence at UCB: Liesbeth Foesters on Leadership in External Manufacturing

  “I believe that if a quality culture is really embedded, the quality organisation starts reducing, because the more quality is embedded in the organisation, the less you need quality to help you think.” – Liesbeth FoestersLiesbeth Foesters, Vice President and Head of External and Clinical Supply Quality at UCB, leads a multinational team of over 130 quality professionals who collaborate across various functions including CMC, supply chain, external manufacturing, and more. With a background in biochemical engineering and extensive experience across multiple quality roles, she brings a unique perspective to quality leadership.In a recent PharmaSource podcast, Liesbeth shared invaluable insights on embedding quality excellence across external manufacturing operations, building effective partnerships with over 100 contract manufacturing organisations (CMOs), and developing leadership approaches that drive engagement and performance.

  --------  

  31:21
• Digital Marketing in Pharma: Sciential's Maurice van Rotterdam Shares His Playbook

  Maurice van Rotterdam, Co-Founder of Netherlands-based digital marketing agency Sciential, believes many pharma suppliers and CDMOs are still missing the mark when it comes to effective digital marketing."If I look at pharma supplier or CDMO websites, they typically have a broad service portfolio and multiple target audiences that need to land on a specific webpage. You might attract a lot of leads, but customers then land on a page that is not working."In the latest episode of the PharmaSource podcast, Maurice shares his playbook for how pharma suppliers can level up their digital marketing game in 2025. He explains key strategies for developing a strong brand identity, distributing highly relevant content, and building personal connections instead of just pushing for leads. It is part of the Niche Demand Preference Model that Sciential have developed for life science companies.Read the full article

  --------  

  37:39

More Science podcasts

Trending Science podcasts

About PharmaSource Podcast